Clinical Trial Update: Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating radiotherapy plus nimotuzumab versus radiotherapy alone in platinum-ineligible locoregionally advanced head and neck s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer | Phase 3 | Status: RECRUITING